Gg Xerozine 15 Ointment
NDC Package 69771-022-23

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Gg Xerozine 15 (skin protectant) ointment is change wet and soiled diapers promptly, cleanse the diaper area and allow to dry.Apply cream liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged. This formulation utilizes a ointment delivery system. Marketed by Geri-gentle Corporation, this product is identified by NDC 69771-022 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
69771-022-23
Package Description
113 g in 1 TUBE
Product Code
69771-022
11-Digit Billing Format
69771002223
RxNorm Crosswalk
  • RxCUI: 2609848 - dimethicone 1 % / zinc oxide 15 % Topical Ointment
  • RxCUI: 2609848 - dimethicone 0.01 MG/MG / zinc oxide 0.15 MG/MG Topical Ointment
  • RxCUI: 2609848 - dimethicone 0.01 MG/MG / ZNO 0.15 MG/MG Topical Ointment

Clinical Specifications

Proprietary Name
Gg Xerozine 15
Non-Proprietary Name
Skin Protectant
Substance Name
Dimethicone; Zinc Oxide
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Skin Barrier Activity - [PE] (Physiologic Effect)
Usage Information
Change wet and soiled diapers promptly, cleanse the diaper area and allow to dry.Apply cream liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged.

Regulatory & Marketing

Labeler Name
Geri-gentle Corporation
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-18-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69771-022-23 identifies a specific commercial package of 113 g in 1 tube of Gg Xerozine 15, a human over the counter drug labeled by Geri-gentle Corporation. This ointment is formulated for topical use and contains dimethicone; zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Geri-gentle Corporation on August 18, 2022. The current certification is valid through December 31, 2027.

How is this Geri-gentle Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69771002223. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69771-022-23
11-Digit CMS (5-4-2)
69771-0022-23

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.